Douglas K M J, Pace A V, Treharne G J, Saratzis A, Nightingale P, Erb N, Banks M J, Kitas G D
Department of Rheumatology, Dudley Group of Hospitals NHS Trust, Russells Hall Hospital, Esk House, Dudley, West Midlands DY1 2HQ, UK.
Ann Rheum Dis. 2006 Mar;65(3):348-53. doi: 10.1136/ard.2005.037978. Epub 2005 Aug 3.
Cardiovascular mortality is increased in rheumatoid arthritis. Possible reasons include an increased incidence of ischaemic heart disease or worse outcome after acute coronary syndrome (ACS).
To assess the outcome of ACS in rheumatoid arthritis compared with case matched controls in the context of underlying cardiac risk factors, clinical presentation, and subsequent management.
40 patients with rheumatoid arthritis and ACS identified from coronary care admission registers between 1990 and 2000 were case matched as closely as possible for age, sex, classical cardiovascular risk factors, type and severity of ACS, and admission date (+/-3 months) with 40 controls. A standardised proforma was used for detailed case note review.
Age, sex, other cardiovascular risk factors, and type and severity of presenting ACS were not significantly different between cases and controls. Recurrent cardiac events were commoner in rheumatoid arthritis (23/40, 57.5%) than controls (12/40, 30%) (p = 0.013); there were 16/40 deaths in rheumatoid arthritis (40%) v 6/40 (15%) in controls (p = 0.012). Recurrent events occurred earlier in rheumatoid arthritis (log rank survival, p = 0.05). Presentation with chest pain occurred in all controls compared with 33/40 rheumatoid patients (82%) (p = 0.006); collapse occurred in one control (2.5%) v 7/40 rheumatoid patients (17.5%) (p = 0.025). Treatment during the ACS was not significantly different in the two groups.
Recurrent ischaemic events and death occur more often after ACS in rheumatoid arthritis. Atypical presentation is commoner in rheumatoid arthritis. There is an urgent need to develop identification and intervention strategies for ACS specific to this high risk group.
类风湿关节炎患者心血管疾病死亡率升高。可能的原因包括缺血性心脏病发病率增加或急性冠状动脉综合征(ACS)后预后更差。
在潜在心脏危险因素、临床表现及后续治疗的背景下,评估类风湿关节炎患者发生ACS后的预后,并与病例匹配的对照组进行比较。
从1990年至2000年冠心病监护病房入院登记中确定40例患有类风湿关节炎且发生ACS的患者,按照年龄、性别、经典心血管危险因素、ACS类型和严重程度以及入院日期(±3个月)与40例对照进行尽可能紧密的病例匹配。使用标准化表格对详细病例记录进行回顾。
病例组和对照组在年龄、性别、其他心血管危险因素以及所呈现的ACS类型和严重程度方面无显著差异。类风湿关节炎患者复发性心脏事件(23/40,57.5%)比对照组(12/40,30%)更常见(p = 0.013);类风湿关节炎患者中有16/40死亡(40%),而对照组为6/40(15%)(p = 0.012)。类风湿关节炎患者复发性事件发生更早(对数秩生存分析,p = 0.05)。所有对照组患者均表现为胸痛,而类风湿关节炎患者中为33/40(82%)(p = 0.006);1例对照组患者(2.5%)出现虚脱,而类风湿关节炎患者中有7/40(17.5%)(p = 0.025)。两组在ACS期间的治疗无显著差异。
类风湿关节炎患者发生ACS后,复发性缺血事件和死亡更常发生。类风湿关节炎患者非典型表现更常见。迫切需要针对这一高危人群制定ACS的识别和干预策略。